Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2877 | 2125 | 43.7 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
269 | 3 | CELL BIOLOGY//CAVEOLIN 1//CAVEOLAE | 44007 |
1911 | 2 | FARNESYLTRANSFERASE//RAS//RAL | 5888 |
2877 | 1 | FARNESYLTRANSFERASE//FARNESYLTRANSFERASE INHIBITOR//PROTEIN FARNESYLTRANSFERASE | 2125 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FARNESYLTRANSFERASE | authKW | 1023190 | 5% | 64% | 111 |
2 | FARNESYLTRANSFERASE INHIBITOR | authKW | 568306 | 3% | 67% | 59 |
3 | PROTEIN FARNESYLTRANSFERASE | authKW | 391152 | 2% | 83% | 33 |
4 | FARNESYLTRANSFERASE INHIBITORS | authKW | 389735 | 2% | 59% | 46 |
5 | PROTEIN PRENYLATION | authKW | 324492 | 2% | 47% | 48 |
6 | LONAFARNIB | authKW | 317968 | 1% | 76% | 29 |
7 | TIPIFARNIB | authKW | 284456 | 2% | 60% | 33 |
8 | PRENYLATION | authKW | 273263 | 4% | 24% | 79 |
9 | FARNESYL TRANSFERASE INHIBITOR | authKW | 216478 | 2% | 42% | 36 |
10 | GERANYLGERANYLTRANSFERASE | authKW | 213786 | 1% | 60% | 25 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 7043 | 18% | 0% | 372 |
2 | Biochemistry & Molecular Biology | 5570 | 44% | 0% | 925 |
3 | Oncology | 1940 | 17% | 0% | 367 |
4 | Chemistry, Organic | 1465 | 13% | 0% | 281 |
5 | Cell Biology | 580 | 10% | 0% | 220 |
6 | Biochemical Research Methods | 384 | 5% | 0% | 115 |
7 | Biophysics | 382 | 6% | 0% | 126 |
8 | Pharmacology & Pharmacy | 187 | 8% | 0% | 173 |
9 | Hematology | 167 | 4% | 0% | 75 |
10 | Mycology | 32 | 1% | 0% | 14 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | KENTUCKY STRUCT BIOL | 133930 | 1% | 55% | 17 |
2 | ANTICANC PROGRAM | 43103 | 0% | 100% | 3 |
3 | DRUG DISCOVERY PROGRAM | 41618 | 2% | 6% | 46 |
4 | GLENOLDEN | 29827 | 0% | 23% | 9 |
5 | IDB CTEP | 28736 | 0% | 100% | 2 |
6 | LUTTE CONTRE CANC CLAUDIUS REGAUD | 28736 | 0% | 100% | 2 |
7 | PROGRAM CANC STEM CELL BIOL | 28421 | 1% | 14% | 14 |
8 | ABT CHEM BIOL | 26429 | 1% | 10% | 19 |
9 | ZENTRUM PHARMAFOR | 22135 | 1% | 9% | 18 |
10 | PROGRAM PROTEASES | 19156 | 0% | 67% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 9350 | 6% | 1% | 129 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 2847 | 8% | 0% | 180 |
3 | JOURNAL OF MEDICINAL CHEMISTRY | 2818 | 3% | 0% | 66 |
4 | BIOORGANIC & MEDICINAL CHEMISTRY | 2579 | 2% | 0% | 49 |
5 | METHODS IN ENZYMOLOGY | 1954 | 2% | 0% | 48 |
6 | BIOCHEMISTRY | 1865 | 4% | 0% | 86 |
7 | CLINICAL CANCER RESEARCH | 1062 | 2% | 0% | 34 |
8 | CANCER RESEARCH | 671 | 2% | 0% | 45 |
9 | MEDCHEMCOMM | 666 | 0% | 1% | 8 |
10 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 523 | 1% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FARNESYLTRANSFERASE | 1023190 | 5% | 64% | 111 | Search FARNESYLTRANSFERASE | Search FARNESYLTRANSFERASE |
2 | FARNESYLTRANSFERASE INHIBITOR | 568306 | 3% | 67% | 59 | Search FARNESYLTRANSFERASE+INHIBITOR | Search FARNESYLTRANSFERASE+INHIBITOR |
3 | PROTEIN FARNESYLTRANSFERASE | 391152 | 2% | 83% | 33 | Search PROTEIN+FARNESYLTRANSFERASE | Search PROTEIN+FARNESYLTRANSFERASE |
4 | FARNESYLTRANSFERASE INHIBITORS | 389735 | 2% | 59% | 46 | Search FARNESYLTRANSFERASE+INHIBITORS | Search FARNESYLTRANSFERASE+INHIBITORS |
5 | PROTEIN PRENYLATION | 324492 | 2% | 47% | 48 | Search PROTEIN+PRENYLATION | Search PROTEIN+PRENYLATION |
6 | LONAFARNIB | 317968 | 1% | 76% | 29 | Search LONAFARNIB | Search LONAFARNIB |
7 | TIPIFARNIB | 284456 | 2% | 60% | 33 | Search TIPIFARNIB | Search TIPIFARNIB |
8 | PRENYLATION | 273263 | 4% | 24% | 79 | Search PRENYLATION | Search PRENYLATION |
9 | FARNESYL TRANSFERASE INHIBITOR | 216478 | 2% | 42% | 36 | Search FARNESYL+TRANSFERASE+INHIBITOR | Search FARNESYL+TRANSFERASE+INHIBITOR |
10 | GERANYLGERANYLTRANSFERASE | 213786 | 1% | 60% | 25 | Search GERANYLGERANYLTRANSFERASE | Search GERANYLGERANYLTRANSFERASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOUSA, SF , FERNANDES, PA , RAMOS, MJ , (2008) FARNESYLTRANSFERASE INHIBITORS: A DETAILED CHEMICAL VIEW ON AN ELUSIVE BIOLOGICAL PROBLEM.CURRENT MEDICINAL CHEMISTRY. VOL. 15. ISSUE 15. P. 1478-1492 | 192 | 85% | 70 |
2 | ZHANG, FL , CASEY, PJ , (1996) PROTEIN PRENYLATION: MOLECULAR MECHANISMS AND FUNCTIONAL CONSEQUENCES.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 65. ISSUE . P. 241-269 | 139 | 70% | 1329 |
3 | MOORTHY, NSHN , SOUSA, SF , RAMOS, MJ , FERNANDES, PA , (2013) FARNESYLTRANSFERASE INHIBITORS: A COMPREHENSIVE REVIEW BASED ON QUANTITATIVE STRUCTURAL ANALYSIS.CURRENT MEDICINAL CHEMISTRY. VOL. 20. ISSUE 38. P. 4888-4923 | 162 | 73% | 9 |
4 | BERNDT, N , HAMILTON, AD , SEBTI, SM , (2011) TARGETING PROTEIN PRENYLATION FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 11. ISSUE 11. P. 775 -791 | 133 | 62% | 163 |
5 | AYRAL-KALOUSTIAN, S , SALASKI, EJ , (2002) PROTEIN FARNESYLTRANSFERASE INHIBITORS.CURRENT MEDICINAL CHEMISTRY. VOL. 9. ISSUE 10. P. 1003 -1032 | 181 | 77% | 35 |
6 | GIBBS, RA , ZAHN, TJ , SEBOLT-LEOPOLD, JS , (2001) NON-PEPTIDIC PRENYLTRANSFERASE INHIBITORS: DIVERSE STRUCTURAL CLASSES AND SURPRISING ANTI-CANCER MECHANISMS.CURRENT MEDICINAL CHEMISTRY. VOL. 8. ISSUE 12. P. 1437 -1465 | 167 | 86% | 30 |
7 | BENETKA, W , KORANDA, M , EISENHABER, F , (2006) PROTEIN PRENYLATION: AN (ALMOST) COMPREHENSIVE OVERVIEW ON DISCOVERY HISTORY, ENZYMOLOGY, AND SIGNIFICANCE IN PHYSIOLOGY AND DISEASE.MONATSHEFTE FUR CHEMIE. VOL. 137. ISSUE 10. P. 1241 -1281 | 212 | 58% | 17 |
8 | LANE, KT , BEESE, LS , (2006) STRUCTURAL BIOLOGY OF PROTEIN FARNESYLTRANSFERASE AND GERANYLGERANYLTRANSFERASE TYPE I.JOURNAL OF LIPID RESEARCH. VOL. 47. ISSUE 4. P. 681-699 | 131 | 77% | 128 |
9 | PALSULEDESAI, CC , DISTEFANO, MD , (2015) PROTEIN PRENYLATION: ENZYMES, THERAPEUTICS, AND BIOTECHNOLOGY APPLICATIONS.ACS CHEMICAL BIOLOGY. VOL. 10. ISSUE 1. P. 51 -62 | 87 | 76% | 18 |
10 | BASSO, AD , KIRSCHMEIER, P , BISHOP, WR , (2006) FARNESYL TRANSFERASE INHIBITORS.JOURNAL OF LIPID RESEARCH. VOL. 47. ISSUE 1. P. 15-31 | 126 | 60% | 193 |
Classes with closest relation at Level 1 |